Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Bjarte Fosby, Espen Melum, Kristian Bjøro, William Bennet, Allan Rasmussen, Ina Marie Andersen, Maria Castedal, Michael Olausson, Christina Wibeck, Mette Gotlieb, Henrik Gjertsen, Leena Toivonen, Stein Foss, Heikki Makisalo, Arno Nordin, Truls Sanengen, Annika Bergquist, Marie E. Larsson, Gunnar Soderdahl, Greg Nowak, Kirsten Muri Boberg, Helena Isoniemi, Susanne Keiding, Aksel Foss, Pål-Dag Line, Styrbjörn Friman, Erik Schrumpf, Bo-Göran Ericzon, Krister Höckerstedt & Tom H. Karlsen. (2015) Liver transplantation in the Nordic countries – An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982–2013. Scandinavian Journal of Gastroenterology 50:6, pages 797-808.
Read now
Read now
Kirsti Numminen, Pekka Tervahartiala, Juha Halavaara, Helena Isoniemi & Krister Höckerstedt. (2005) Non-invasive diagnosis of liver cirrhosis: Magnetic resonance imaging presents special features. Scandinavian Journal of Gastroenterology 40:1, pages 76-82.
Read now
Read now
B. Brandsæter, S. Friman, U. Broomé, H. Isoniemi, M. Olausson, L. Bäckman, B. Hansen, E. Schrumpf, A. Oksanen, B.‐G. Ericzon, K. Höckerstedt, H. Mäkisalo, P. Kirkegaard & K. Bjøro. (2003) Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scandinavian Journal of Gastroenterology 38:11, pages 1176-1183.
Read now
Read now
Articles from other publishers (29)
Alexander H. Shannon, Samantha M. Ruff, Austin D. Schenk, Kenneth Washburn & Timothy M. Pawlik. (2023) Updates and Expert Opinions on Liver Transplantation for Gastrointestinal Malignancies. Medicina 59:7, pages 1290.
Crossref
Crossref
Ping-Jui Yu, Cheng-Maw Ho, Chih-Yang Hsiao, Yao-Ming Wu, Ming-Chih Ho, Po-Huang Lee & Rey-Heng Hu. (2023) Longitudinal analysis of transplant candidates with primary sclerosing cholangitis in an Asian liver transplant center. European Journal of Gastroenterology & Hepatology 35:4, pages 480-487.
Crossref
Crossref
Matthew Peverelle, Sarang Paleri, Jed Hughes, Peter De Cruz & Paul J Gow. (2020) Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes. Inflammatory Bowel Diseases 26:12, pages 1901-1908.
Crossref
Crossref
O. Edeghere, N.Q. Verlander, J. Aboulhab, A. Costella, H.E. Harris, M.A. Balogun & M.E. Ramsay. (2015) Retrospective cohort study of liver transplantation in the United Kingdom between 1994 and 2010: the impact of hepatitis C infection. Public Health 129:5, pages 509-516.
Crossref
Crossref
Anna Lepistö, Sari Kivistö, Leena Kivisaari, Johanna Arola & Heikki J. Järvinen. (2009) Primary sclerosing cholangitis: outcome of patients undergoing restorative proctocolecetomy for ulcerative colitis. International Journal of Colorectal Disease 24:10, pages 1169-1174.
Crossref
Crossref
Sumihito Tamura, Yasuhiko Sugawara, Junichi Kaneko, Junichi Togashi, Yuichi Matsui, Noriyo Yamashiki, Norihiro Kokudo & Masatoshi Makuuchi. (2008) Recurrence of cholestatic liver disease after living donor liver transplantation. World Journal of Gastroenterology 14:33, pages 5105.
Crossref
Crossref
Espen Melum, Styrbjörn Friman, Kristian Bjøro, Allan Rasmussen, Helena Isoniemi, Henrik Gjertsen, Lars Bäckman, Antti Oksanen, Michael Olausson, Frans F. Duraj & Bo-Göran Ericzon. (2007) Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma. Journal of Hepatology 47:6, pages 777-783.
Crossref
Crossref
G. Kenneth Johnson, Kia Saeian & Joseph E. Geenen. (2006) Primary sclerosing cholangitis treated by endoscopic biliary dilation: Review and long-term follow-up evaluation. Current Gastroenterology Reports 8:2, pages 147-155.
Crossref
Crossref
J. L. Vincent. 2006. Intensive Care Medicine in 10 Years. Intensive Care Medicine in 10 Years
3
21
.
Seth D Crockett & Emmet B Keeffe. (2005) Current perspectives: liver transplantation in the elderly. Aging Health 1:1, pages 59-76.
Crossref
Crossref
A.J. DEMETRIS, MIKE NALESNIK, PARMJEET RANDHAWA, TONG WU, MARIDA MINERVINI, CHI LAI & ZHENGBIN LU. 2005. Transplantation of the Liver. Transplantation of the Liver
1057
1128
.
LARS BÄCKMAN, JOHN L.R. FORSYTHE, BIANCA MIRANDA, NATIVIDAD CUENDE, JOSE CAÑÓN, CARLOS MARGARIT, TILL GERLING & GUIDO G. PERSIJN. 2005. Transplantation of the Liver. Transplantation of the Liver
79
91
.
K. M. Boberg & E. Schrumpf. 2005. Autoimmune Liver Disease. Autoimmune Liver Disease
233
246
.
E. Schrumpf & K. M. Boberg. 2005. Autoimmune Liver Disease. Autoimmune Liver Disease
203
207
.
B Brandsæter, Helena Isoniemi, Ulrika Broomé, Michael Olausson, Lars Bäckman, Bent Hansen, Erik Schrumpf, Antti Oksanen, Bo-Göran Ericzon, Krister Höckerstedt, Heikki Mäkisalo, Preben Kirkegaard, Styrbjörn Friman & Kristian Bjøro. (2004) Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. Journal of Hepatology 40:5, pages 815-822.
Crossref
Crossref
Kristian Bjøro & Erik Schrumpf. (2004) Liver transplantation for primary sclerosing cholangitis. Journal of Hepatology 40:4, pages 570-577.
Crossref
Crossref
B Brandsæter. (2003) Liver transplantation for primary sclerosing cholangitis in the Nordic countries: Outcome after acceptance to the waiting list. Liver Transplantation 9:9, pages 961-969.
Crossref
Crossref
K. Bj??ro, B. G. Ericzon, P. Kirkegaard, K. H??ckerstedt, G. S??derdahl, M. Olausson, A. Foss, L. E. Schmidt, H. Isoniemi, B. Brands??ter & S. Friman. (2003) Highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation. Transplantation 75:3, pages 347-353.
Crossref
Crossref
Bjørn Brandsaeter, Krister Höckerstedt, Styrbjörn Friman, Bo-Göran Ericzon, Preben Kirkegaard, Helena Isoniemi, Michael Olausson, Ulrika Broome, Lars Schmidt, Aksel Foss & Kristian Bjøro. (2002) Fulminant hepatic failure: Outcome after listing for highly urgent liver transplantation-12 years experience in the nordic countries. Liver Transplantation 8:11, pages 1055-1062.
Crossref
Crossref
Erik Schrumpf & Kirsten Muri Boberg. (2002) Endoscopic treatment for primary sclerosing cholangitis?. Journal of Hepatology 36:2, pages 278-279.
Crossref
Crossref
Jean-Christophe Weber & Daniel Jaeck. 2002. Multi-Treatment Modalities of Liver Tumours. Multi-Treatment Modalities of Liver Tumours
77
83
.
B.-G Ericzon, K Bjoro, K Hoeckerstedt, B Hanssen, M Olausson, H Isoniemi, P Kirkegaard, G Soderdahl, A Foss & S Friman. (2001) Time to request ABO-identity when transplanting for fulminant hepatic failure?. Transplantation Proceedings 33:7-8, pages 3466-3467.
Crossref
Crossref
Erik Schrumpf & Kirsten Muri Boberg. (2001) Epidemiology of primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 15:4, pages 553-562.
Crossref
Crossref
K Bjøro, P Kirkegaard, B.G Ericzon, S Friman, E Schrumpf, H Isoniemi, G Herlenius, M Olausson, A Rasmussen, A Foss & K Höckerstedt. (2001) Is a 3-day limit for highly urgent liver transplantation for fulminant hepatic failure appropriate, and is the diagnosis in some cases incorrect?. Transplantation Proceedings 33:4, pages 2511-2513.
Crossref
Crossref
Robert G. Gish & Andrew Mason. (2001) AUTOIMMUNE LIVER DISEASE. Clinics in Liver Disease 5:2, pages 287-314.
Crossref
Crossref
E. Schrumpf & K.M. Boberg. (2000) Primary sclerosing cholangitis: challenges of a new millenium. Digestive and Liver Disease 32:9, pages 753-755.
Crossref
Crossref
Eduardo B. Martins & Roger W. Chapman. (2000) Sclerosing cholangitis. Current Opinion in Gastroenterology 16:5, pages 444-449.
Crossref
Crossref
H. J. Toivonen. (2001) Anaesthesia for patients with a transplanted organ. Acta Anaesthesiologica Scandinavica 44:7, pages 812-833.
Crossref
Crossref
K. Bjøro, K. Höckerstedt, B.G. Ericzon, S. Friman, A. Hjortrup, S. Keiding, E. Schrumpf, F. Duraj, M. Olausson, H. Mäkisalo, A. Bergan & P. Kirkegaard. (2000) Liver transplantation in patients over 60 years of age. Transplant International 13:S1, pages S165-S170.
Crossref
Crossref